Brian A. Teras


Fax: 404.873.8623
171 17th Street NW
Suite 2100
Atlanta, Georgia 30363


Brian is a partner in the Corporate & Securities practice. He counsels companies as they undertake major, and often transformational, financial transactions. He works with public and private companies on securities, corporate finance and corporate governance matters. He also advises in connection with structuring, negotiating, and completing mergers, acquisitions, divestitures, and joint ventures. As a trusted professional, Brian guides clients through SEC reporting and compliance including Section 13 and Section 16 obligations, Rule 144 matters, preparation of ’34 Act reports, NYSE and NASDAQ rules compliance, proxy statements, and general disclosure obligations under the federal securities laws. He also works with issuers in securities and corporate finance transactions, including registered offerings, private offerings (including Reg D, Rule 144A and Reg A+ offerings), consent solicitations, and tender and exchange offers involving debt and equity securities. When helping companies in corporate governance matters, Brian advises on board of directors’ duties, executive compensation, board and shareholder meetings, and administration of compensation/equity plans. In his legal practice, Brian draws from the business acumen gained from his time as in-house counsel for an Atlanta-based publicly traded life sciences company.


  • Represented a publicly traded healthcare services provider in the following:

    • Registered secondary offering of common stock
    • $75 million acquisition of a specialty healthcare company and other roll-up acquisitions
    • $250 million Rule 144A senior notes offering
  • Represented a publicly traded life sciences company in the following:

    • Acquisition of an add-on regenerative medicine company
    • $50 million revolving credit facility
  • Represented a private investment firm in the acquisition of multiple machine lubrication businesses

  • Represented an investor group in connection with the acquisition of a minority interest in a national sports franchise

  • Represented a specialty contract research organization (CRO) in $150 million acquisition by a publicly-traded CRO

  • Represented a private equity fund in the acquisition of an automotive chemicals company

  • Represented a publicly traded healthcare IT company in the following:

    • Initial public offering (IPO) and NYSE listing
    • $640 million sale of the company to a large private equity firm
  • Represented a transportation company in the following:

    • Dividend recap and issuance of $150 million of senior notes
    • $225 million Rule 144A senior secured notes offering and related tender offer for existing debt
    • $150 million acquisition financing (Rule 144A secured notes offering)
    • Private placement of approximately $70 million of secured notes and preferred stock
  • Represented an environmental services company in several roll-up acquisitions

  • Represented a national homebuilder in the following:

    • $300 million Rule 144A senior notes offering
    • $50 million Rule 144A tack-on notes offering


  • Georgia State University College of Law, Juris Doctor,
    magna cum laude
    • Editorial Board, Georgia State University Law Review
  • University of Wisconsin-Madison, Bachelor of Arts
  • State of Georgia 2006
    • State Bar of Georgia
    • American Bar Association
    • Society for Corporate Governance


  • Georgia “Super Lawyers Rising Stars,” Securities & Corporate Finance (2010, 2012)

News & Insights